The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.
This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,490 trial records at the last sync on 25 Sep 2026, 03:16 UTC; this register shows the 2,500 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.
This page shows the 6 of those trials with a site in Netherlands that also match the filters currently applied.
6 of the 2,500 most recently authorised trials in this register list a site in Netherlands and match the filters applied; 3 of them are Phase III. Trials are counted by authorisation on CTIS, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.
| Phase | Trials | Share |
|---|---|---|
| Phase III | 3 | 50% |
| Phase II | 2 | 33.3% |
| Phase I/II | 1 | 16.7% |
| Lead sponsor | Trials |
|---|---|
| AbbVie Deutschland GmbH & Co. KG | 1 |
| Academisch Ziekenhuis Maastricht | 1 |
| Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A. | 1 |
| Bristol-Myers Squibb Services Unlimited Company | 1 |
| Merus B.V. | 1 |
| Radboud universitair medisch centrum Stichting | 1 |